KNS-760704 regulatory update

EMEA's Committee for Orphan Medicinal Products (COMP) issued a positive opinion to grant Orphan Drug designation for Knopp's KNS-760704 to treat amyotrophic lateral sclerosis (ALS). The optical enanti...